| Schmitz, Norbert |
R-CHOEP-brut, NCT03399513: Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma |
|
|
| Completed | 2 | 40 | Europe | Ibrutinib Oral Capsule [Imbruvica], R-CHOEP chemotherapy | University Hospital Muenster, Janssen-Cilag G.m.b.H | Diffuse Large B Cell Lymphoma | 12/23 | 12/23 | | |
| Lenz, Philipp |
| Completed | N/A | 34 | Europe | Telemedicine | University Hospital Muenster, Palliativnetz Muenster gGmbH, CompuGroup Medical | Cancer, Chronic Heart Failure, Chronic Obstructive Pulmonary Disease, Palliative Care | 10/21 | 02/22 | | |
| Recruiting | N/A | 300 | Europe | Spiritual Needs Questionnaire | University Hospital Muenster | Cancer, Heart Failure, Chronic Obstructive Pulmonary Disease, Lateral Sclerosis | 05/24 | 12/24 | | |
EntMedPall, NCT06648733: Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care |
|
|
| Recruiting | N/A | 200 | Europe | Structured pharmaceutical discharge management | University Hospital Muenster, University Hospital Munich | Cancer, Heart Failure, COPD | 06/25 | 12/25 | | |
| Heinzow, Hauke |
| Recruiting | N/A | 1200 | Europe | UDCA, ursodeoxycholic acid, Ocaliva, obeticholic acid | University of Leipzig, RWTH Aachen University, Zentrum für Klinische Studien Leipzig, Intercept Pharma Europe Limited (IPEL), Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University Hospital Erlangen, Medical care center for Gastroenterology, Berlin, Institute for Interdisciplinary Medicine, Hamburg, Leberhilfe Projekt gUG, Cologne, Hannover Medical School | PBC, Primary Biliary Cholangitis | 03/24 | 03/24 | | |
| Vogel, Thomas |
NCT04720326: Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients |
|
|
| Active, not recruiting | 4 | 268 | Europe | Tacrolimus Pill, Envarsus, Tacrolimus capsule, Advagraf | Edward Geissler, Chiesi Pharmaceuticals GmbH, Excelya | Prophylaxis Against Liver Transplant Rejection | 01/24 | 10/26 | | |
| Completed | N/A | 100 | Europe | | University Hospital, Strasbourg, France | Peptic Ulcer Disease | 06/20 | 08/20 | | |
| Recruiting | N/A | 2000 | Europe | | University Hospital, Strasbourg, France | Venous Thromboembolic Disease | 04/23 | 04/23 | | |
| Becker, Karsten |
SeCo, NCT04370119: Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers |
|
|
| Active, not recruiting | N/A | 1092 | Europe | Nasal swab, Serum testing | University Medicine Greifswald, Friedrich Loefler Institute for Animal Health, EUROIMMUN AG | SARS-CoV-2 | 04/21 | 05/25 | | |
| Recruiting | N/A | 124 | Europe | Checklist-based phone calls | University Medicine Greifswald | Staphylococcus Aureus Bacteremia | 01/25 | 04/25 | | |
| Calaminus, Gabriele |
| Recruiting | 3 | 167 | Europe | Temozolomide + Valproic Acid | University of Göttingen, Deutsche Kinderkrebsstiftung, Hannover Medical School | Glioblastoma WHO Grade IV, Diffuse Midline Glioma Histone 3 K27M WHO Grade IV, Anaplastic Astrocytoma WHO Grade III, Diffuse Intrinsic Pontine Glioma, Gliomatosis Cerebri | 12/23 | 12/23 | | |
| Schliemann, Christoph |
TRIANGLE, NCT02858258: ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma |
|
|
| Recruiting | 3 | 870 | Europe | R-CHOP/R-DHAP, rituximab, CHOP, DHAP, Ibrutinib (Induction), Imbruvica, ASCT conditioning, THAM or BEAM, Ibrutinib (Maintenance) | Prof. Dr. M. Dreyling (co-chairman), LMU Klinikum | Mantle Cell Lymphoma | 05/21 | 05/26 | | |
|
| Completed | 3 | 721 | Europe, RoW | study part 1 - dose daunorubicin, induction cycles | Technische Universität Dresden, University Hospital Dresden, Masaryk University | Leukemia, Myelocytic, Acute | 04/22 | 04/22 | | |
| Recruiting | 3 | 102 | Europe | Onfekafusp alfa, L19TNF, Doxorubicin | Philogen S.p.A. | Soft Tissue Sarcoma | 12/25 | 12/25 | | |
| Recruiting | 3 | 550 | Europe, Canada, US, RoW | Tamibarotene, SY-1425, Placebo, Azacitidine | Syros Pharmaceuticals | Myelodysplastic Syndromes | 11/24 | 02/29 | | |
| Recruiting | 3 | 126 | Europe | Trabectedin, Yondelis, tTF-NGR | Universität Münster, Anturec Pharmaceuticals GmbH | Soft Tissue Sarcoma | 12/25 | 12/26 | | |
| Active, not recruiting | 2 | 98 | Europe | Dacarbazine, DTIC, onfekafusp alfa, L19TNF | Philogen S.p.A., Philogen S.p.A., | Soft Tissue Sarcoma | 12/25 | 12/25 | | |
| Recruiting | 2 | 146 | Europe | Venetoclax plus Azacitidine, standard of care chemotherapy plus gemtuzumab ozogamicin | Technische Universität Dresden, University Hospital Heidelberg, AbbVie | Acute Myeloid Leukemia | 09/28 | 09/28 | | |
| Active, not recruiting | 1/2 | 55 | Europe | Venetoclax Oral Tablet, Cytarabin | Technische Universität Dresden, AbbVie | Relapsed Adult AML, Refractory AML | 10/23 | 08/25 | | |
| Recruiting | 1/2 | 214 | Europe | MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO, Rydapt, Mylotarg, MAGNOLIA-trial: Midostaurin associated with conventional chemotherapy (AraC+DNR)+GO, MAGNOLIA-trial: conventional chemotherapy (AraC+DNR)+GO, MAGMA-trial:GO associated with conventional chemotherapy (AraC+DNR)+Midostaurin, MAGMA-trial: conventional chemotherapy (AraC+DNR)+Midostaurin | Technische Universität Dresden, Novartis Pharmaceuticals, Pfizer | Acute Myeloid Leukemia | 04/27 | 04/28 | | |
| Zarbock, Alexander |
| Completed | 3 | 64 | Europe | Angiotensin II, Control | Westfälische Wilhelms-Universität Münster, German Research Foundation | Cardiac Surgery, Vasoplegia, Hyperreninemia | 12/22 | 03/23 | | |
| Recruiting | 3 | 710 | Europe | Acyclovir, Aciclovir | Jena University Hospital | Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia, Herpes Simplex, Hospital-acquired Pneumonia | 07/26 | 12/26 | | |
| Recruiting | 3 | 2470 | Europe | red blood cell transfusion trigger | Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital | Transfusion-dependent Anemia, Surgery, Anemia | 12/24 | 12/25 | | |
PAN-AKI, NCT06615102: Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II |
|
|
| Not yet recruiting | 3 | 1022 | NA | Angiotensin II, Noradrenalin | Universität Münster, German Research Foundation | Cardiac Surgery, Vasoplegia | 01/27 | 04/27 | | |
EPO-TRAUMA, NCT04588311: ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients |
|
|
| Recruiting | 3 | 2500 | Europe, RoW | Epoetin Alfa 40000 UNT/ML, Eprex, Binocrit, Sodium Chloride 0.9%, Placebo, Saline | Australian and New Zealand Intensive Care Research Centre, University College Dublin, Medical Research Institute of New Zealand, Medical Research Future Fund, Health Research Board, Ireland, Health Research Council, New Zealand, Irish Critical Care Clinical Trials Network, ANZICS Clinical Trials Group, Monash University | Trauma, Traumatic Injury, Traumatic Brain Injury, Wounds and Injuries, Penetrating Injury, Blunt Injury, Major Trauma, Multiple Trauma | 12/25 | 12/25 | | |
AKITA, NCT05126303: Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery |
|
|
| Terminated | 2 | 177 | Europe, Canada, US, RoW | RMC-035, ROSgard, Placebo | Guard Therapeutics AB | Acute Kidney Injury | 04/23 | 07/23 | | |
MODIFYCSX, NCT06279793: Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients |
|
|
| Recruiting | 2 | 120 | Europe | Long-chain n-3 fatty acids, Omegaven®, Intravenous 0.9% Sodium Chloride, Saline Infusion | GCP-Service International West GmbH, University Hospital, Bonn, University Hospital Muenster, University Hospital Goettingen, University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital | Cardiac Surgery, High Risk Patients, Intensive Care Unit, Cardiopulmonary Bypass, Valve Surgeries | 12/24 | 12/25 | | |
| Recruiting | 2 | 66 | Europe, US | Reparixin 600mg, REP, Matching Placebo, Control | Dompé Farmaceutici S.p.A, Dompè farmaceutici s.p.a. | Acute Respiratory Distress Syndrome, Adult | 08/25 | 08/25 | | |
NCT03567577 / 2017-003855-47: Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS |
|
|
| Recruiting | 2 | 95 | Europe | Solnatide 25 mg powder for reconstitution for solution for inhalation, AP301, 0.9% Saline Solution | Apeptico Forschung und Entwicklung GmbH | ARDS | 12/24 | 12/24 | | |
POINTER, NCT06475274: A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery |
|
|
| Recruiting | 2 | 161 | Europe, Canada | RMC-035, Placebo | Guard Therapeutics AB | Kidney Injury Following Open-Chest Cardiac Surgery | 10/25 | 10/25 | | |
| Recruiting | N/A | 72 | Europe | Bronchoscopy, blood sampling; testing. | University Hospital Muenster, Study Chair and Principal Investigator: Univ.-Prof. Dr. Alexander Zarbock, Principal Investigator: Dr. Andreas Margraf | ARDS, Platelet Abnormality | 03/23 | 03/23 | | |
| Recruiting | N/A | 40 | Europe | on-pump surgery, off-pump surgery | Universität Münster | Vasoplegia, Vasoplegic Shock | 05/25 | 08/25 | | |
| Recruiting | N/A | 257 | Europe | Nephroprotective measures | Universität Münster | Acute Kidney Injury | 03/25 | 09/25 | | |
| Recruiting | N/A | 600 | Europe, RoW | Critically ill patients with continuous renal replacement therapy | University Hospital Muenster, Baxter Healthcare Corporation | Critically Ill, Continuous Renal Replacement Therapy, Infections | 05/25 | 08/25 | | |
| Not yet recruiting | N/A | 60 | NA | No study-specific interventions | University Hospital Muenster | Acute Kidney Injury | 10/24 | 12/24 | | |
NCT05925348: Endotoxinemia and Vasoplegia Following Cardiothoracic Surgery With Cardiopulmonary Bypass (CPB) |
|
|
| Recruiting | N/A | 200 | Europe | Patients with cardiopulmonary bypass | Westfälische Wilhelms-Universität Münster | Vasoplegia, Vasoplegic Shock | 12/24 | 01/25 | | |
| Recruiting | N/A | 165 | Europe | Effluent dose of CRRT | Universität Münster | Critical Illness, Acute Kidney Injury | 04/25 | 06/25 | | |
| Lenz, Georg |
TRIANGLE, NCT02858258: ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma |
|
|
| Recruiting | 3 | 870 | Europe | R-CHOP/R-DHAP, rituximab, CHOP, DHAP, Ibrutinib (Induction), Imbruvica, ASCT conditioning, THAM or BEAM, Ibrutinib (Maintenance) | Prof. Dr. M. Dreyling (co-chairman), LMU Klinikum | Mantle Cell Lymphoma | 05/21 | 05/26 | | |
|
COPA-R-CHOP, NCT04263584: Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL |
|
|
| Active, not recruiting | 2 | 62 | Europe | Copanlisib, R-CHOP Chemotherapy | University Hospital Muenster, Bayer | Diffuse Large B Cell Lymphoma | 04/25 | 04/25 | | |
| Claus, Inga |
NCT05357989 / 2022-001542-38: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD |
|
|
| Completed | 3 | 523 | Europe, US | buntanetap/posiphen, Posiphen Tartrate, ANVS401, Placebo | Annovis Bio Inc., TFS Trial Form Support | Parkinson's Disease, Idiopathic | 12/23 | 12/23 | | |
| Completed | 3 | 507 | Europe, US, RoW | Tavapadon, PF-06649751, CVL-751, Placebo | Cerevel Therapeutics, LLC | Parkinson Disease | 01/24 | 02/24 | | |
| Completed | 3 | 522 | Europe, Canada, US, RoW | Tavapadon, PF-06649751, CVL-751, Placebo | Cerevel Therapeutics, LLC | Parkinson Disease | 06/24 | 06/24 | | |
| Active, not recruiting | 2 | 159 | Europe, Japan, US | TAK-341, MEDI1341, Placebo | Takeda, AstraZeneca | Multiple System Atrophy | 07/25 | 07/25 | | |
EMST-PS, NCT05139342: Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients |
|
|
| Recruiting | N/A | 75 | Europe | expiratory muscle strentgh training (EMST) | Kliniken Beelitz GmbH | Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy | 08/23 | 12/23 | | |
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies |
|
|
| Recruiting | N/A | 200 | Europe, Japan, RoW | | Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona | Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy | 12/23 | 07/24 | | |
| Trebicka, Jonel |
CARP, NCT05551299: Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy |
|
|
| Recruiting | 4 | 258 | Europe | Photosensitizer, Photodynamic therapy (PDT), Radiofrequency ablation (RFA) | University of Leipzig, Zentrum für Klinische Studien Leipzig | Hilar Cholangiocarcinoma | 04/28 | 04/28 | | |
| Completed | 3 | 410 | Europe, Canada, US, RoW | Albutein 20% Injectable Solution, Standard medical treatment | Grifols Therapeutics LLC, Instituto Grifols, S.A. | Decompensated Cirrhosis and Ascites | 05/24 | 05/24 | | |
| Active, not recruiting | 3 | 238 | Europe, Canada, Japan, US, RoW | Linerixibat, Placebo | GlaxoSmithKline | Pruritus | 10/24 | 01/25 | | |
NCT05056220: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites |
|
|
| Recruiting | 3 | 240 | Europe | Human albumin, sodium chloride | Aleksander Krag, EASL - CLIF Consortium | Decompensated Cirrhosis and Ascites | 03/25 | 04/25 | | |
| Recruiting | 3 | 380 | Europe, US | SMT + PE-A 5%, Albutein 5%, Standard Medical Treatment, SMT | Grifols Therapeutics LLC, Instituto Grifols, S.A. | Acute-On-Chronic Liver Failure | 10/26 | 10/26 | | |
| Recruiting | 3 | 251 | Europe, Canada, Japan, US, RoW | Linerixibat | GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited | Cholestasis | 02/27 | 02/27 | | |
COMBAT, NCT05895136: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome ( Trial). |
|
|
| Recruiting | 2 | 90 | Europe | Human albumin, Enoxaparin, Standard medical treatment | European Foundation for Study of Chronic Liver Failure | Liver Cirrhosis | 03/25 | 03/25 | | |
DETECT, NCT06523608: Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease |
|
|
| Recruiting | N/A | 600 | Europe | Standard survillance protocol, Stratified survillance protocol | University Hospital Muenster | Liver Diseases, Hepatocellular Carcinoma, Hepatocarcinoma, Advanced Chronic Liver Disease | 09/25 | 09/27 | | |
| Recruiting | N/A | 124 | Europe | TIPS, Standard of Care, Terlipressin + Albumin | Jena University Hospital, German Research Foundation, University Hospital Halle (Saale) | Cirrhosis, Liver, Hepatorenal Syndrome, Acute Kidney Injury, Ascites Hepatic | 06/25 | 06/26 | | |
NCT03584204: Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome |
|
|
| Recruiting | N/A | 400 | Europe | imaging | University Hospital, Bonn, University of Roma La Sapienza | Liver Cirrhosis | 07/25 | 08/26 | | |
| Recruiting | N/A | 1000 | Europe | | Johann Wolfgang Goethe University Hospital | Liver Cirrhosis, Acute-On-Chronic Liver Failure, Portal Hypertension | 09/25 | 12/25 | | |
CHANCE, NCT04613921: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs |
|
|
| Recruiting | N/A | 3000 | Europe, Canada, Japan, US, RoW | Observational Protocol | European Foundation for Study of Chronic Liver Failure | Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications | 12/25 | 12/26 | | |
| Recruiting | N/A | 196 | Europe | Transjugular intrahepatic portosystemic shunt, TIPS | W.L.Gore & Associates | Chronic Liver Disease | 01/25 | 01/28 | | |
| Steinbicker, Andrea |
| Recruiting | N/A | 100 | Europe | | Goethe University, Pharmacosmos A/S, University Hospital Muenster | Anemia, IV Iron | 12/23 | 12/23 | | |
| Zarbock |
AKITA, NCT05126303: Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery |
|
|
| Terminated | 2 | 177 | Europe, Canada, US, RoW | RMC-035, ROSgard, Placebo | Guard Therapeutics AB | Acute Kidney Injury | 04/23 | 07/23 | | |
| Recruiting | N/A | 600 | Europe, RoW | Critically ill patients with continuous renal replacement therapy | University Hospital Muenster, Baxter Healthcare Corporation | Critically Ill, Continuous Renal Replacement Therapy, Infections | 05/25 | 08/25 | | |
| Completed | N/A | 1180 | Europe | Comprehensive Implementation of the Bundle recommended by the "Kidney Disease: Improving Global Outcomes Group" (KDIGO bundle) | University Hospital Muenster, BioMérieux | Acute Kidney Injury | 06/24 | 09/24 | | |
PrevProgAKI, NCT05275218: Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery |
|
|
| Recruiting | N/A | 480 | Europe | Implementation of the KDIGO bundle) | University Hospital Muenster, Baxter Healthcare Corporation | Acute Kidney Injury (Nontraumatic) | 09/25 | 12/25 | | |
| Berdel, Wolfgang |
NCT03188874: Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) |
|
|
| Recruiting | N/A | 15000 | Europe | | Technische Universität Dresden | Acute Myeloid Leukemia (AML) | 09/30 | 09/30 | | |
| Meersch, Melanie |
| Terminated | 3 | 440 | Europe | Albutein® 200 g/L or Plasbumin® 20, Human Albumin 20% | Jena University Hospital, German Research Foundation, Instituto Grifols, S.A., University Hospital Goettingen, SepNet - Critical Care Trials Group, Center for Sepsis Control and Care, Germany | Septic Shock | 07/22 | 06/23 | | |
| Recruiting | 3 | 2470 | Europe | red blood cell transfusion trigger | Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital | Transfusion-dependent Anemia, Surgery, Anemia | 12/24 | 12/25 | | |
| Completed | N/A | 43 | Europe | Standard coagulation profile, Specific coagulation tests, Bleeding Scores | University Hospital, Ghent | Bleeding Disorder, Extra Corporeal Life Support, Thrombosis | 01/23 | 04/24 | | |
| Schwake, Anna-Lena |
NCT05357989 / 2022-001542-38: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD |
|
|
| Completed | 3 | 523 | Europe, US | buntanetap/posiphen, Posiphen Tartrate, ANVS401, Placebo | Annovis Bio Inc., TFS Trial Form Support | Parkinson's Disease, Idiopathic | 12/23 | 12/23 | | |
| Piekarski, Florian |
MODIFYCSX, NCT06279793: Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients |
|
|
| Recruiting | 2 | 120 | Europe | Long-chain n-3 fatty acids, Omegaven®, Intravenous 0.9% Sodium Chloride, Saline Infusion | GCP-Service International West GmbH, University Hospital, Bonn, University Hospital Muenster, University Hospital Goettingen, University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital | Cardiac Surgery, High Risk Patients, Intensive Care Unit, Cardiopulmonary Bypass, Valve Surgeries | 12/24 | 12/25 | | |
| Kyriakou, Andreas |
NCT04645914: Influence of the Consumption of Conventional and Electric Cigarettes on Skin Circulation |
|
|
| Recruiting | N/A | 198 | Europe | Use of nicotine product (smoking/vaping) | University Hospital Muenster | Nicotine Dependence, Vaping, Smoking | 05/22 | 12/22 | | |
| Margraf, Andreas |
| Recruiting | N/A | 72 | Europe | Bronchoscopy, blood sampling; testing. | University Hospital Muenster, Study Chair and Principal Investigator: Univ.-Prof. Dr. Alexander Zarbock, Principal Investigator: Dr. Andreas Margraf | ARDS, Platelet Abnormality | 03/23 | 03/23 | | |
| Wempe, Carola |
| Recruiting | 3 | 710 | Europe | Acyclovir, Aciclovir | Jena University Hospital | Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia, Herpes Simplex, Hospital-acquired Pneumonia | 07/26 | 12/26 | | |
MODIFYCSX, NCT06279793: Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients |
|
|
| Recruiting | 2 | 120 | Europe | Long-chain n-3 fatty acids, Omegaven®, Intravenous 0.9% Sodium Chloride, Saline Infusion | GCP-Service International West GmbH, University Hospital, Bonn, University Hospital Muenster, University Hospital Goettingen, University Hospital Schleswig-Holstein, Charite University, Berlin, Germany, Wuerzburg University Hospital | Cardiac Surgery, High Risk Patients, Intensive Care Unit, Cardiopulmonary Bypass, Valve Surgeries | 12/24 | 12/25 | | |
| Recruiting | N/A | 72 | Europe | Bronchoscopy, blood sampling; testing. | University Hospital Muenster, Study Chair and Principal Investigator: Univ.-Prof. Dr. Alexander Zarbock, Principal Investigator: Dr. Andreas Margraf | ARDS, Platelet Abnormality | 03/23 | 03/23 | | |
SiCa-Flam, NCT05725798: Perioperative Sitagliptin Medication for Reduction of the Inflammatory Response Associated With Cardiopulmonary Bypass |
|
|
| Completed | N/A | 20 | Europe | Sitagliptin | University Hospital Muenster | Systemic Inflammatory Response Syndrome | 05/23 | 08/23 | | |
NCT05703802: Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia. |
|
|
| Completed | N/A | 30 | Europe | Procalcitonin-variants ELISA-Assay | University Hospital Muenster | Sepsis, Pre-Eclampsia, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Adiposity, SIRS, Procalcitonin | 11/22 | 11/22 | | |
| Schwab, Nicholas |
| Completed | N/A | 18 | Europe | 311 nm narrowband UVB irradiation | University Hospital Muenster | Multiple Sclerosis | 04/23 | 04/23 | | |
| Klaas, Christoph |
EntMedPall, NCT06648733: Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care |
|
|
| Recruiting | N/A | 200 | Europe | Structured pharmaceutical discharge management | University Hospital Muenster, University Hospital Munich | Cancer, Heart Failure, COPD | 06/25 | 12/25 | | |
